TATAA Biocenter

2023年3月31日

分享這篇文章提供的新聞分享本文哥德堡,瑞典,3月31日2023 / TATAA從Biocenter,高質量的分子分析服務的領先供應商,今天宣布,它已成為一個認證合格的服務提供者為高溫凝膠分子診斷。這個認證將使TATAA提供高吞吐量,多重基因表達分析其客戶,並擴大其投資組合的分子分析服務。高溫凝膠分子診斷是一個生命科學公司通過創新推進精密醫學transcriptome-wide分析技術、高溫凝膠EdgeSeq™。這個高度敏感和具體方法分析基因表達可以讓研究人員研究同時大量的基因。研究這項技術是特別有用的應用程序,需要複雜的基因表達譜的分析,如腫瘤學、免疫學和神經學研究。與RNA-Seq不同,高溫凝膠EdgeSeq技術不需要RNA提取,並可使用少量的組織材料,通常幾平方毫米,生成可再生的基因表達譜。“我們正興奮的認證合格的服務提供者高溫凝膠技術,“說的創始人兼首席執行官TATAA Biocenter米凱爾Kubista。“我們的科學家小組已經在廣泛的培訓在這個技術,我們裝備精良,為我們的客戶提供高質量的服務,高通量、多路複用基因表達分析。”"Your commitment to excellence and dedication to providing a top-notch service has been truly inspiring and we are thrilled to have you as a partner," said Selina Gaertner, Director, EU Medical Affairs, HTG Molecular Diagnostics. "We are really pleased to count TATAA Biocenter among our limited number of Qualified Service Providers. They represent the perfect service we need to recommend to our end users, running our technology with high standards and professionalism," stated Jean Claude Gerard Vice President, Global Sales, HTG Molecular Diagnostics. "This certification reflects our commitment to providing our customers with the most advanced genomic services available. With HTG EdgeSeq technology, we can now offer even more comprehensive solutions for gene expression profiling and biomarker discovery," added Jens Björkman, COO, TATAA Biocenter. TATAA Biocenter is a pioneer in qPCR, digital PCR, and Next-Generation Sequencing (NGS) services and products, serving customers in academia, industry, and healthcare. With this certification, TATAA Biocenter continues to expand its portfolio of advanced molecular biology technologies, providing its clients with the most innovative and reliable solutions for their research and clinical needs. Contact for more info: